Megan Roche

555 total citations
11 papers, 422 citations indexed

About

Megan Roche is a scholar working on Cancer Research, Molecular Biology and Rheumatology. According to data from OpenAlex, Megan Roche has authored 11 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 4 papers in Molecular Biology and 3 papers in Rheumatology. Recurrent topics in Megan Roche's work include Cancer, Hypoxia, and Metabolism (6 papers), Cancer-related molecular mechanisms research (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Megan Roche is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Cancer-related molecular mechanisms research (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Megan Roche collaborates with scholars based in United States, Spain and Netherlands. Megan Roche's co-authors include Ubaldo Martinez‐Outschoorn, Marina Domingo‐Vidal, Joseph Curry, Nancy J. Philp, Lindsay Wilde, Diana Whitaker‐Menezes, Madalina Tuluc, Ying‐Hui Ko, Ramón Bartrons and Patrick Tassone and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Megan Roche

10 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Megan Roche United States	8	256	246	100	67	52	11	422
Fangzhu Wan China	11	291 1.1×	186 0.8×	143 1.4×	82 1.2×	55 1.1×	17	492
Jue‐Yu Zhou China	15	426 1.7×	278 1.1×	110 1.1×	42 0.6×	54 1.0×	42	591
Liwen Zhang China	12	311 1.2×	257 1.0×	83 0.8×	69 1.0×	48 0.9×	25	509
Suhua Xia China	14	314 1.2×	220 0.9×	127 1.3×	74 1.1×	63 1.2×	24	520
Αναστασία Κοττόρου Greece	15	245 1.0×	175 0.7×	172 1.7×	91 1.4×	71 1.4×	37	510
Yu Yin China	13	329 1.3×	254 1.0×	106 1.1×	35 0.5×	94 1.8×	30	525
Songwang Cai China	13	315 1.2×	186 0.8×	154 1.5×	31 0.5×	66 1.3×	33	516
Yifeng Cui China	9	311 1.2×	281 1.1×	61 0.6×	37 0.6×	67 1.3×	20	494
Ralitsa R. Madsen United Kingdom	11	280 1.1×	104 0.4×	103 1.0×	41 0.6×	55 1.1×	18	499

Countries citing papers authored by Megan Roche

Since Specialization

Citations

This map shows the geographic impact of Megan Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Roche more than expected).

Fields of papers citing papers by Megan Roche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Roche. The network helps show where Megan Roche may publish in the future.

Co-authorship network of co-authors of Megan Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Megan Roche. A scholar is included among the top collaborators of Megan Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan Roche. Megan Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Roche, Megan, Zhao Lin, Diana Whitaker‐Menezes, et al.. (2025). TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis. Molecular Oncology. 19(8). 2431–2455.

Zhao, Lin, Megan Roche, Marina Domingo‐Vidal, et al.. (2024). MiR-200c reprograms fibroblasts to recapitulate the phenotype of CAFs in breast cancer progression. SHILAP Revista de lepidopterología. 8. 1–20. 2 indexed citations

Roche, Megan, Ying‐Hui Ko, Marina Domingo‐Vidal, et al.. (2023). TP53 Induced Glycolysis and Apoptosis Regulator and Monocarboxylate Transporter 4 drive metabolic reprogramming with c‐MYC and NFkB activation in breast cancer. International Journal of Cancer. 153(9). 1671–1683. 18 indexed citations

Roche, Megan, et al.. (2023). Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment. Best Practice & Research Clinical Haematology. 36(4). 101514–101514. 11 indexed citations

Whitaker‐Menezes, Diana, et al.. (2022). Uremic Myopathy and Mitochondrial Dysfunction in Kidney Disease. International Journal of Molecular Sciences. 23(21). 13515–13515. 4 indexed citations

Roche, Megan, et al.. (2021). Metabolic Pathways and Targets in Chondrosarcoma. Frontiers in Oncology. 11. 772263–772263. 15 indexed citations

Zhao, Lin, Diana Whitaker‐Menezes, Marina Domingo‐Vidal, et al.. (2021). Macrophage and adipocyte interaction as a source of inflammation in kidney disease. Scientific Reports. 11(1). 2974–2974. 18 indexed citations

Roche, Megan, Lin Zhao, Diana Whitaker‐Menezes, et al.. (2020). Translocase of the outer mitochondrial membrane complex subunit 20 (TOMM20) facilitates cancer aggressiveness and therapeutic resistance in chondrosarcoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(12). 165962–165962. 24 indexed citations

Wilde, Lindsay, Megan Roche, Marina Domingo‐Vidal, et al.. (2017). Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development. Seminars in Oncology. 44(3). 198–203. 262 indexed citations

10.

Tassone, Patrick, Marina Domingo‐Vidal, Diana Whitaker‐Menezes, et al.. (2017). Metformin Effects on Metabolic Coupling and Tumor Growth in Oral Cavity Squamous Cell Carcinoma Coinjection Xenografts. Otolaryngology. 158(5). 867–877. 9 indexed citations

11.

Ko, Ying‐Hui, Marina Domingo‐Vidal, Megan Roche, et al.. (2016). TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer. Journal of Biological Chemistry. 291(51). 26291–26303. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact